Archer ensures accurate, reliable data collection by eliminating operational burdens and providing validated, regulatory-grade data integrations, significantly reducing the need for Source Data Verification (SDV) on a scalable, agnostic platform.
Data Inaccuracy and High Costs: Minimize data errors and source data verification (SDV) inefficiencies that drive nearly 25% of the clinical study budget.
Time Constraints: Shorten clinical trial timelines with expedited data collection and verification.
Regulatory Compliance and Resource Management: Achieve regulatory compliance and real-time-clinical-trial capabilities through human-in-the-loop workflows.
Archer has proven to cut time to receive site data by up to 85%, offering the potential to speed up clinical studies. This boosts data analysis, decision-making, and can accelerate the speed to database lock. Together this allows sponsors to shorten time to market, addresses trial risks faster, and focus resources on the most effective research.
Archer cuts SDV costs, which can be up to 25% of a study’s budget. When leveraging Archer solely for labs and vitals it can reduce data queries by 89%, expand to include other data domains and reduce queries further.
Archer’s human-in-the-loop design ensures regulatory-compliant data transfers, maintaining clinical trial integrity. It’s trusted in regulatory-grade trials, ensuring top traceability and auditability.
Premier sites cite Archer as a competitive advantage by providing a simple and efficient clinical trial process. Leveraging Archer demonstrates an investment in data interoperability solutions that are proven to improve the performance of site staff in data collection and transfer.
Archer was built specifically to connect disparate technologies and integrate all vendor platforms used for clinical trials directly into one tool. Archer is fully agnostic for all source and EHR data inputs as well as all sponsor data capture systems, enabling seamless integration across clinical trials.
We are proud to have a 100% site retention rate among top ranked research sites. IgniteData is engaged with 80% of the National Cancer Institute’s Designated Cancer Centers, as well as 19 of the top 30 cancer centers in the US and institutions across 6 countries.
The IgniteData Alliance is a commitment to connecting this innovative site network to sponsors for collaboration and partnership.
Archer functions exclusively as a data processor, ensuring that no personally identifiable information (PHI) is retained or stored, thus providing top-tier data security.
Transform your clinical trials with Archer’s unparalleled accuracy and efficiency. Request a demo or contact us at sales@ignitedata.com to learn more.
